It would have been interesting to have sat in on the senior management meetings at Merck that thrashed out the Organon ...

Jennifer Halchak; VP, IR; Organon & Co. Kevin Ali; Chief Executive Officer, Director; Organon & Co. Matthew Walsh; Chief Financial Officer, Senior Vice President; Or ...

JERSEY CITY, N.J.--(BUSINESS WIRE)--Organon (NYSE: OGN) a global healthcare company with a focus on women’s health, today announced the appointment of Ramona A. Sequeira, President of the Global ...

This news release contains certain forward-looking statements relating to BAT8006, BAT8008, BAT8010, BAT1006, BAT1308 or the product pipelines in general of Bio-Thera Solutions. Readers are ...

At the top of April, Organon announced the acquisition of Tofidence (tocilizumab-bavi), a biosimilar approved by the FDA in October 2023 for the treatment of rheumatoid arthritis, giant cell arteritis ...